(secondQuint)EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma.

.

 Prospective randomised clinical study in patients with adenocarcinoma of the pancreas.

 Patients will be randomised 1:1.

 Patients in the treatment group will receive standard chemotherapy plus 3 radiofrequency ablation procedures, each one month apart.

 Patients in the control group will receive standard chemotherapy and best medical care.

.

 EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma.

@highlight

This study will assess if endoscopic ultrasound radiofrequency application in patients with inoperable pancreatic cancer and chemotherapy confers survival benefit when compared to patients receiving best medical care and chemotherapy .

